News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medical Device Biz Arch Therapeutics Brings in $7.3 Million Round


7/10/2013 9:23:48 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Arch Therapeutics Inc., a medical device startup which has developed a product to stop bleeding, has secured $7.3 million in funding, according to a recent filing with the U.S. Securities and Exchange Commission. Listing as directors in the filing are Arthur Rosenthal, former CSO at Boston Scientific; Dr. Terrance Norchi, CEO and Co-founder of Arch; and Avtar Dhillon, chairman of Arch and chairman of Inovio Pharmaceuticals Inc. Alan Barber, CFO, is also listed in the filing. The Cambridge, Mass.-based company has developed AC5, a synthetic peptide that has naturally occurring amino acids. When it is applied onto a wound, the product fills the areas of the connective tissue and then provides a barrier to leaking substances including blood and other bodily fluids.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES